Latest News about SAGE
Recent news which mentions SAGE
From Motley Fool
 
   Why Shares of Sage Therapeutics Slumped This Week
   
  
  
  August 11, 2023
  From Motley Fool
 
   Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
   
  
  
  August 11, 2023
  From Benzinga
 
   2 Beaten-Down Stocks That Still Aren't Worth Buying
   
  
  
  August 11, 2023
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
   
  
  
  August 08, 2023
  From Benzinga
 
   Is Sage Therapeutics a Contrarian Buy?
   
  
  
  August 08, 2023
  From Motley Fool
 From Benzinga
 
   Dow Gains 1%; Tabula Rasa HealthCare Shares Spike Higher
   
  
  
  August 07, 2023
  From Benzinga
 
   What More Can Support Biogen/Sage's Zuranolone Resubmission: Analysts See Uncertain Road Ahead
   
  
  
  August 07, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  August 07, 2023
  From Benzinga
 
   Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
   
  
  
  August 07, 2023
  From Benzinga
 
   FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
   
  
  
  August 07, 2023
  From Benzinga
 
   Crude Oil Down Over 1%; Henry Schein Earnings Top Views
   
  
  
  August 07, 2023
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
   
  
  
  August 07, 2023
  From Benzinga
 
   Sage Therapeutics’ stock drops 49% after FDA approves zuranolone for postpartum depression but not for major depressive disorder
   
  
  
  August 07, 2023
  From MarketWatch
 From Benzinga
 From InvestorPlace
 
   Dow Jumps 250 Points; Tyson Foods Posts Downbeat Results
   
  
  
  August 07, 2023
  From Benzinga
 
   Why Is Sage Therapeutics (SAGE) Stock Down 48% Today?
   
  
  
  August 07, 2023
  From InvestorPlace
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  August 07, 2023
  From Benzinga
 
   FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
   
  
  
  August 07, 2023
  From Benzinga
 From Benzinga
 From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.